Crossmark

Radiopharmaceutical development of alpha mangostin derivative [131I]I-AMB10: radiosynthesis, in silico, and cellular internalization against human breast cancer cell lines

Crossref DOI link: https://doi.org/10.1007/s10967-025-10531-2

Published Online: 2025-12-01

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Daruwati, Isti

Mardianingrum, Richa

Setiadi, Yanuar

Susilo, Veronika Yulianti

Forentin, Alfian Mahardika

Pertiwi, Ligwina Dita

Ruswanto,

Sugiharti, Rizky Juwita

Achmad, Tri Hanggono

Syaifudin, Mukh

Muchtaridi, Muchtaridi https://orcid.org/0000-0002-6156-8025
Funding

Funding for this research was provided by:

Universitas Padjadjaran (1503/UN6.3.1/PT.00/2024)
License Information

Text and Data Mining valid from 2025-12-01

Version of Record valid from 2025-12-01
More Information

Article History

Received: 27 March 2025

Accepted: 5 November 2025

First Online: 1 December 2025

Declarations

:

: The authors declare no conflict of interest.

: Not applicable.

Document is current

Any future updates will be listed below